Bacterial Effector Binding to Ribosomal Protein S3 Subverts NF-κB Function

被引:131
作者
Gao, Xiaofei [1 ]
Wan, Fengyi [2 ]
Mateo, Kristina [3 ]
Callegari, Eduardo [4 ]
Wang, Dan [3 ]
Deng, Wanyin [5 ]
Puente, Jose [6 ]
Li, Feng [3 ]
Chaussee, Michael S. [4 ]
Finlay, B. Brett [5 ]
Lenardo, Michael J. [2 ]
Hardwidge, Philip R. [1 ]
机构
[1] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA
[2] NIAID, Immunol Lab, Bethesda, MD 20892 USA
[3] S Dakota State Univ, Dept Vet Sci, Brookings, SD 57007 USA
[4] Univ S Dakota, Div Basic Biomed Sci, Sanford Sch Med, Vermillion, SD 57069 USA
[5] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada
[6] Univ Nacl Autonoma Mexico, Dept Mol Microbiol, Cuernavaca 62191, Morelos, Mexico
关键词
ENTEROPATHOGENIC ESCHERICHIA-COLI; INTESTINAL EPITHELIAL-CELLS; HEMOLYTIC-UREMIC SYNDROME; INNATE IMMUNE-RESPONSES; III SECRETION; FLUORESCENCE COMPLEMENTATION; CITROBACTER-RODENTIUM; VIRULENCE FACTOR; DNA-REPAIR; NON-LOCUS;
D O I
10.1371/journal.ppat.1000708
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Enteric bacterial pathogens cause food borne disease, which constitutes an enormous economic and health burden. Enterohemorrhagic Escherichia coli (EHEC) causes a severe bloody diarrhea following transmission to humans through various means, including contaminated beef and vegetable products, water, or through contact with animals. EHEC also causes a potentially fatal kidney disease (hemolytic uremic syndrome) for which there is no effective treatment or prophylaxis. EHEC and other enteric pathogens (e. g., enteropathogenic E. coli (EPEC), Salmonella, Shigella, Yersinia) utilize a type III secretion system (T3SS) to inject virulence proteins (effectors) into host cells. While it is known that T3SS effectors subvert host cell function to promote diarrheal disease and bacterial transmission, in many cases, the mechanisms by which these effectors bind to host proteins and disrupt the normal function of intestinal epithelial cells have not been completely characterized. In this study, we present evidence that the E. coli O157:H7 nleH1 and nleH2 genes encode T3SS effectors that bind to the human ribosomal protein S3 (RPS3), a subunit of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) transcriptional complexes. NleH1 and NleH2 co-localized with RPS3 in the cytoplasm, but not in cell nuclei. The N-terminal region of both NleH1 and NleH2 was required for binding to the N-terminus of RPS3. NleH1 and NleH2 are autophosphorylated Ser/Thr protein kinases, but their binding to RPS3 is independent of kinase activity. NleH1, but not NleH2, reduced the nuclear abundance of RPS3 without altering the p50 or p65 NF-kappa B subunits or affecting the phosphorylation state or abundance of the inhibitory NF-kappa B chaperone I kappa B alpha NleH1 repressed the transcription of a RPS3/NF-kappa B-dependent reporter plasmid, but did not inhibit the transcription of RPS3-independent reporters. In contrast, NleH2 stimulated RPS3-dependent transcription, as well as an AP-1-dependent reporter. We identified a region of NleH1 (N40-K45) that is at least partially responsible for the inhibitory activity of NleH1 toward RPS3. Deleting nleH1 from E. coli O157: H7 produced a hypervirulent phenotype in a gnotobiotic piglet model of Shiga toxin-producing E. coli infection. We suggest that NleH may disrupt host innate immune responses by binding to a cofactor of host transcriptional complexes.
引用
收藏
页数:18
相关论文
共 77 条
[1]   TLR signaling in the gut in health and disease [J].
Abreu, MT ;
Fukata, M ;
Arditi, M .
JOURNAL OF IMMUNOLOGY, 2005, 174 (08) :4453-4460
[2]   Role of BfpF, a member of the PilT family of putative nucleotide-binding proteins, in type IV pilus biogenesis and in interactions between enteropathogenic Escherichia coli and host cells [J].
Anantha, RP ;
Stone, KD ;
Donnenberg, MS .
INFECTION AND IMMUNITY, 1998, 66 (01) :122-131
[3]   An injected bacterial effector targets chromatin access for transcription factor NF-κB to alter transcription of host genes involved in immune responses [J].
Arbibe, Laurence ;
Kim, Dong Wook ;
Batsche, Eric ;
Pedron, Thierry ;
Mateescu, Bogdan ;
Muchardt, Christian ;
Parsot, Claude ;
Sansonetti, Philippe J. .
NATURE IMMUNOLOGY, 2007, 8 (01) :47-56
[4]   Differences in virulence among Escherichia coli O157: H7 strains isolated from humans during disease outbreaks and from healthy cattle [J].
Baker, Diane R. ;
Moxley, Rodney A. ;
Steele, Mike B. ;
LeJeune, Jeffrey T. ;
Christopher-Hennings, Jane ;
Chen, Ding-Geng ;
Hardwidge, Philip R. ;
Francis, David H. .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2007, 73 (22) :7338-7346
[5]  
Berghöfer-Hochheimer Y, 1998, J CELL BIOCHEM, V69, P1, DOI 10.1002/(SICI)1097-4644(19980401)69:1<1::AID-JCB1>3.0.CO
[6]  
2-X
[7]   Manipulation of host-cell pathways by bacterial pathogens [J].
Bhavsar, Amit P. ;
Guttman, Julian A. ;
Finlay, B. Brett .
NATURE, 2007, 449 (7164) :827-834
[8]   EspFU is a translocated EHEC effector that interacts with Tir and N-WASP and promotes nck-independent actin assembly [J].
Campellone, KG ;
Robbins, D ;
Leong, JM .
DEVELOPMENTAL CELL, 2004, 7 (02) :217-228
[9]   IκB genetic polymorphisms and invasive pneurnococxal disease [J].
Chapman, Stephen J. ;
Khor, Chiea C. ;
Vannberg, Fredrik O. ;
Frodsham, Angela ;
Walley, Andrew ;
Maskell, Nicholas A. ;
Davies, Christopher W. H. ;
Segal, Shelley ;
Moore, Catrin E. ;
Gillespie, Stephen H. ;
Denny, Paul ;
Day, Nicholas P. ;
Crook, Derrick W. ;
Davies, Robert J. O. ;
Hill, Adrian V. S. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (02) :181-187
[10]   Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 β-lactamase as a new fluorescence-based reporter [J].
Charpentier, X ;
Oswald, E .
JOURNAL OF BACTERIOLOGY, 2004, 186 (16) :5486-5495